481 related articles for article (PubMed ID: 30563885)
1. Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline.
Prasad K; Siemieniuk R; Hao Q; Guyatt G; O'Donnell M; Lytvyn L; Heen AF; Agoritsas T; Vandvik PO; Gorthi SP; Fisch L; Jusufovic M; Muller J; Booth B; Horton E; Fraiz A; Siemieniuk J; Fobuzi AC; Katragunta N; Rochwerg B
BMJ; 2018 Dec; 363():k5130. PubMed ID: 30563885
[TBL] [Abstract][Full Text] [Related]
2. Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis.
Hao Q; Tampi M; O'Donnell M; Foroutan F; Siemieniuk RA; Guyatt G
BMJ; 2018 Dec; 363():k5108. PubMed ID: 30563866
[TBL] [Abstract][Full Text] [Related]
3. Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT.
Bath PM; Woodhouse LJ; Appleton JP; Beridze M; Christensen H; Dineen RA; Flaherty K; Duley L; England TJ; Havard D; Heptinstall S; James M; Kasonde C; Krishnan K; Markus HS; Montgomery AA; Pocock S; Randall M; Ranta A; Robinson TG; Scutt P; Venables GS; Sprigg N
Health Technol Assess; 2018 Aug; 22(48):1-76. PubMed ID: 30179153
[TBL] [Abstract][Full Text] [Related]
4. Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials.
Kheiri B; Osman M; Abdalla A; Haykal T; Swaid B; Ahmed S; Chahine A; Hassan M; Bachuwa G; Al Qasmi M; Bhatt DL
J Thromb Thrombolysis; 2019 Feb; 47(2):233-247. PubMed ID: 30511260
[TBL] [Abstract][Full Text] [Related]
5. Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial.
Wangqin R; Wang X; Wang Y; Xian Y; Zhao X; Liu L; Li H; Meng X; Wang Y
Stroke Vasc Neurol; 2017 Dec; 2(4):176-183. PubMed ID: 29507777
[TBL] [Abstract][Full Text] [Related]
6. Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials.
Pan Y; Elm JJ; Li H; Easton JD; Wang Y; Farrant M; Meng X; Kim AS; Zhao X; Meurer WJ; Liu L; Dietrich D; Wang Y; Johnston SC
JAMA Neurol; 2019 Dec; 76(12):1466-1473. PubMed ID: 31424481
[TBL] [Abstract][Full Text] [Related]
7. Dual Antiplatelet Therapy in Transient Ischemic Attack and Minor Stroke With Different Infarction Patterns: Subgroup Analysis of the CHANCE Randomized Clinical Trial.
Jing J; Meng X; Zhao X; Liu L; Wang A; Pan Y; Li H; Wang D; Johnston SC; Wang Y; Wang Y
JAMA Neurol; 2018 Jun; 75(6):711-719. PubMed ID: 29582084
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
[TBL] [Abstract][Full Text] [Related]
9. [Dual antiplatelet therapy for secondary stroke prevention in patients with acute ischemic stroke. CIERTO group recommendation].
Izcovich A; Caruso D; Tisi Baña M; Bottaro F; Pollán J; Saavedra E; Catalano HN
Medicina (B Aires); 2019; 79(4):315-321. PubMed ID: 31487255
[TBL] [Abstract][Full Text] [Related]
10. Contemporary antiplatelet therapy for secondary stroke prevention: a narrative review of current literature and guidelines.
Shah J; Liu S; Yu W
Stroke Vasc Neurol; 2022 Oct; 7(5):406-414. PubMed ID: 35393359
[TBL] [Abstract][Full Text] [Related]
11. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.
Johnston SC; Easton JD; Farrant M; Barsan W; Conwit RA; Elm JJ; Kim AS; Lindblad AS; Palesch YY;
N Engl J Med; 2018 Jul; 379(3):215-225. PubMed ID: 29766750
[TBL] [Abstract][Full Text] [Related]
12. Treatment Effect of Clopidogrel Plus Aspirin Within 12 Hours of Acute Minor Stroke or Transient Ischemic Attack.
Li Z; Wang Y; Zhao X; Liu L; Wang D; Wang C; Meng X; Li H; Pan Y; Wang X; Wang C; Yang X; Zhang C; Jing J; Xian Y; Johnston SC; Wang Y;
J Am Heart Assoc; 2016 Mar; 5(3):e003038. PubMed ID: 27001965
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet treatment for acute secondary prevention of non-cardioembolic minor stroke / transient ischaemic attack: an update for the acute physician.
Krishnan K; Law ZK; Minhas JS; Bath PM; Robinson TG; Sprigg N; Mavilakandy A; England TJ; Eveson D; Mistri A; Dawson J; Appleton JP
Clin Med (Lond); 2022 Sep; 22(5):449-454. PubMed ID: 36507812
[TBL] [Abstract][Full Text] [Related]
14. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
Hankey GJ
Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
[TBL] [Abstract][Full Text] [Related]
15. Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: A review of the evidence.
Davis KA; Miyares MA; Dietrich E
Am J Health Syst Pharm; 2015 Oct; 72(19):1623-9. PubMed ID: 26386103
[TBL] [Abstract][Full Text] [Related]
16. The influence of mean arterial pressure on the efficacy and safety of dual antiplatelet therapy in minor stroke or transient ischemic attack patients.
Ma Y; Liu Y; Xu J; Wang Y; Du F; Wang Y
J Clin Hypertens (Greenwich); 2019 May; 21(5):598-604. PubMed ID: 30957391
[TBL] [Abstract][Full Text] [Related]
17. Short- vs. long-term dual antiplatelet therapy in secondary prevention for ischaemic stroke: a network metanalysis.
Pugliese F; Arasaratnam P; Moellenberg M; Dani S
Eur Heart J Qual Care Clin Outcomes; 2019 Oct; 5(4):298-309. PubMed ID: 31050716
[TBL] [Abstract][Full Text] [Related]
18. Ticagrelor versus clopidogrel in dual antiplatelet therapy after minor stroke or transient ischemic attack: an updated network meta-analysis.
Marinheiro G; Araújo B; Monteiro GA; Leite M; Mutarelli A; Almeida AM; Cavalcante-Neto JF; Rivera A; Pinheiro AC; Telles JPM
J Neurol; 2024 Jun; 271(6):3030-3038. PubMed ID: 38580815
[TBL] [Abstract][Full Text] [Related]
19. New opportunities to optimize antithrombotic therapy for secondary stroke prevention.
Kim AS; Easton JD
Int J Stroke; 2019 Apr; 14(3):220-222. PubMed ID: 30722755
[TBL] [Abstract][Full Text] [Related]
20. Effect of dual versus mono antiplatelet therapy on recurrent stroke modulated by activated partial thromboplastin time.
Xie X; Wang X; Laskowitz DT; Zhao X; Miao Z; Liu L; Li H; Meng X; Wang Y; Wang Y;
Eur J Neurol; 2019 Sep; 26(9):1168-e78. PubMed ID: 30972875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
